Literature DB >> 29607133

Should ultrathin strut drug eluting stents be considered the new benchmark for novel coronary stents approval? The complex interplay between stent strut thickness, polymeric carriers and antiproliferative drugs.

Alessandro Lupi1, Alon Schaffer1, Angelo Sante Bongo2.   

Abstract

Year:  2018        PMID： 29607133      PMCID： PMC5864588          DOI： 10.21037/jtd.2018.01.108

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  23 in total

1.  Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial.

Authors:  Stephan Windecker; Michael Haude; Franz-Josef Neumann; Karl Stangl; Bernhard Witzenbichler; Ton Slagboom; Manel Sabaté; Javier Goicolea; Paul Barragan; Stéphane Cook; Christophe Piot; Gert Richardt; Béla Merkely; Henrik Schneider; Johannes Bilger; Paul Erne; Ron Waksman; Serge Zaugg; Peter Jüni; Thierry Lefèvre
Journal:  Circ Cardiovasc Interv       Date:  2015-02       Impact factor: 6.546

2.  Clinical and biomechanical behavior of a platinum-chromium stent platform in a large all-comer single-center population: insights from the Novara-PROMETEUS registry.

Authors:  Alessandro Lupi; Italo Porto; Andrea Rognoni; Maurizio Lazzero; Rossella Fattori; Rosario Parisi; Giovanni Luigi De Maria; Angelo Sante Bongo; Imad Sheiban; Leonardo Bolognese; Pierfrancesco Agostoni; Gioel Gabrio Secco
Journal:  J Invasive Cardiol       Date:  2014-07       Impact factor: 2.022

3.  Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT VII Trial.

Authors:  Lisette Okkels Jensen; Per Thayssen; Michael Maeng; Jan Ravkilde; Lars Romer Krusell; Bent Raungaard; Anders Junker; Christian Juhl Terkelsen; Karsten Tange Veien; Anton Boel Villadsen; Anne Kaltoft; Hans-Henrik Tilsted; Knud Nørregaard Hansen; Jens Aaroe; Steen Dalby Kristensen; Henrik Steen Hansen; Svend Eggert Jensen; Morten Madsen; Hans Erik Bøtker; Klára Berencsi; Jens Flensted Lassen; Evald Høj Christiansen
Journal:  Circ Cardiovasc Interv       Date:  2016-07       Impact factor: 6.546

4.  Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial.

Authors:  A Kastrati; J Mehilli; J Dirschinger; F Dotzer; H Schühlen; F J Neumann; M Fleckenstein; C Pfafferott; M Seyfarth; A Schömig
Journal:  Circulation       Date:  2001-06-12       Impact factor: 29.690

5.  Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.

Authors:  Thomas Pilgrim; Dik Heg; Marco Roffi; David Tüller; Olivier Muller; André Vuilliomenet; Stéphane Cook; Daniel Weilenmann; Christoph Kaiser; Peiman Jamshidi; Therese Fahrni; Aris Moschovitis; Stéphane Noble; Franz R Eberli; Peter Wenaweser; Peter Jüni; Stephan Windecker
Journal:  Lancet       Date:  2014-09-01       Impact factor: 79.321

6.  Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Authors:  Ian T Meredith; Stefan Verheye; Christophe Dubois; Joseph Dens; Bruno Farah; Didier Carrié; Simon Walsh; Keith Oldroyd; Olivier Varenne; Seif El-Jack; Raul Moreno; Thomas Christen; Dominic J Allocco
Journal:  EuroIntervention       Date:  2018-04-20       Impact factor: 6.534

7.  Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial.

Authors:  David E Kandzari; Laura Mauri; Jacques J Koolen; Joseph M Massaro; Gheorghe Doros; Hector M Garcia-Garcia; Johan Bennett; Ariel Roguin; Elie G Gharib; Donald E Cutlip; Ron Waksman
Journal:  Lancet       Date:  2017-08-26       Impact factor: 79.321

Review 8.  Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials.

Authors:  Kyung Woo Park; Si-Hyuck Kang; Matthijs A Velders; Dong-Ho Shin; Seokyung Hahn; Woo-Hyun Lim; Han-Mo Yang; Hae-Young Lee; Adrianus J Van Boven; Sjoerd H Hofma; Hyun-Jae Kang; Bon-Kwon Koo; Byung-Hee Oh; Young-Bae Park; David E Kandzari; Hyo-Soo Kim
Journal:  Am Heart J       Date:  2012-12-27       Impact factor: 4.749

Review 9.  Impact of technological developments in drug-eluting stents on patient-focused outcomes: a pooled direct and indirect comparison of randomised trials comparing first- and second-generation drug-eluting stents.

Authors:  Humberto Colmenarez; Cristina Fernández; Javier Escaned
Journal:  EuroIntervention       Date:  2014-12       Impact factor: 6.534

10.  A randomized, prospective, intercontinental evaluation of a bioresorbable polymer sirolimus-eluting coronary stent system: the CENTURY II (Clinical Evaluation of New Terumo Drug-Eluting Coronary Stent System in the Treatment of Patients with Coronary Artery Disease) trial.

Authors:  Shigeru Saito; Mariano Valdes-Chavarri; Gert Richardt; Raul Moreno; Andrés Iniguez Romo; Emanuele Barbato; Didier Carrie; Kenji Ando; Bela Merkely; Ran Kornowski; Hélène Eltchaninoff; Stefan James; William Wijns
Journal:  Eur Heart J       Date:  2014-05-19       Impact factor: 29.983
View more
  4 in total

Review 1.  Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?

Authors:  Allen J Weiss; Marta Lorente-Ros; Ashish Correa; Nitin Barman; Jacqueline E Tamis-Holland
Journal:  Curr Atheroscler Rep       Date:  2022-07-11       Impact factor: 5.967

2.  Triglyceride to high-density lipoprotein cholesterol ratio as a risk factor of repeat revascularization among patients with acute coronary syndrome after first-time percutaneous coronary intervention.

Authors:  Ya-Min Su; Rui Zhang; Rong-Feng Xu; Hong-Lei Wang; Hai-Hua Geng; Min Pan; Yang-Yang Qu; Wen-Jie Zuo; Zhen-Jun Ji; Gen-Shan Ma
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

3.  Safety and Clinical Performance of Biodegradable Polymer-Coated Ultra-Thin Everolimus-Eluting Stents in "Real-World" Patients: A Multicenter Registry (PERFORM-EVER).

Authors:  Sridhar Kasturi; Srinivas Polasa; Mohammad Ali Sowdagar; Praveen Kumar; Thejanandan Reddy; Chaitanya Nichenamatla; Shailender Singh; Vijaykumar Reddy
Journal:  Anatol J Cardiol       Date:  2022-08       Impact factor: 1.475

4.  Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.

Authors:  Atul Abhyankar; Alexandre Abizaid; Daniel Chamié; Mihir Rathod
Journal:  Catheter Cardiovasc Interv       Date:  2020-04-03       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.